SCHEMBL6567653

SCHEMBL6567653

COC(=O)c1cc(NC(=O)Nc2cccc(OC)c2)ccc1OC(c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.56
GRIK1 P39086 1/20 0.53
TP53 P04637 2/20 0.52
TSHR P16473 2/20 0.52
MAPT P10636 9/20 0.52
MEN1 O00255 6/20 0.52
KMT2A Q03164 6/20 0.52
HTT P42858 4/20 0.52
NPC1 O15118 4/20 0.52
RAB9A P51151 4/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
LMNA P02545 3/20 0.52
NPSR1 Q6W5P4 1/20 0.52
PKM P14618 1/20 0.52
UTS2R Q9UKP6 2/20 0.52
IDH1 O75874 1/20 0.51
ALDH1A1 P00352 2/20 0.49
MAPK1 P28482 2/20 0.49
TRPV1 Q8NER1 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567997 0.91 MAPT (0.56) TP53TSHRMAPTMEN1KMT2A
SCHEMBL6564618 0.91 TP53 (0.53) TP53TSHRMAPTMEN1KMT2A
SCHEMBL6564574 0.91 TSHR (0.55) TP53TSHRMAPTMEN1KMT2A
SCHEMBL6564507 0.91 MEN1 (0.55) CNR1GRIK1TP53TSHRMAPT
SCHEMBL6564666 0.87 MEN1 (0.54) CNR1TP53MAPTMEN1KMT2A
SCHEMBL6564600 0.86 MEN1 (0.59) CNR1TP53MAPTMEN1KMT2A
SCHEMBL6566965 0.86 MEN1 (0.51) TP53MAPTMEN1KMT2AHTT
SCHEMBL6565909 0.85 MEN1 (0.49) CNR1TP53MAPTMEN1KMT2A
SCHEMBL6567055 0.84 MEN1 (0.64) GRIK1TP53TSHRMAPTMEN1
SCHEMBL6568164 0.83 MEN1 (0.50) TP53TSHRMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 CNR1 22/4885GRIK1 816/4885TP53 4453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.